- Multiple sclerosis
Clyde E. Markowitz, MD
Neurology
Accepting new patients
Sees patients age 18 and up
Penn Neuroscience Center - Neurology
Penn Medicine Provider
About me
- Director, Multiple Sclerosis Center at Penn
- Associate Professor of Neurology at the Hospital of the University of Pennsylvania
My education and training
- Medical School: Columbia University
- Residency: NewYork–Presbyterian Hospital
- Fellowship: NewYork-Presbyterian/Columbia University Medical Center
Spoken languages
English
English
Reviews
828 reviews
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Insurance accepted
Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.
- Aetna Advantra Cares D-SNP
- Aetna Advantra Credit Value
- Aetna Advantra Eagle HMO
- Aetna Advantra Eagle POS
- Aetna Advantra Premier Plus PPO
- Aetna Advantra Value
- Aetna Advantra Value Plus
- Aetna APCN Plus (Multi-Tier)
- Aetna Better Health Kids (CHIP) - DH Only
- Aetna Flexible Five
- Aetna Freedom Core
- Aetna Gold
- Aetna HMO
- Aetna Philly Prime
- Aetna POS
- Aetna PPO APCN
- Aetna Premier
- Aetna Premier Plus
- Aetna Savings Plus
- Aetna Signature Administrators
- Aetna Student Health Plan PPO
- Aetna Upfront Advantage
- First Health HMO
- First Health POS
- First Health PPO
- Meritain - Aramark (Other)
- Meritain - Aramark (Pennsylvania Premier Medical Plan)
- Centivo EPO
- Cigna Healthcare EPO
- Cigna Healthcare HMO
- Cigna Healthcare POS
- Cigna Healthcare PPO
- Claim Watcher (Homestead/ INDECs) Open Access
- Clover Health Choice
- Clover Health Choice Value PPO
- Clover Health Classic HMO
- Clover Health Value
- Devoted Health Choice Giveback Pennsylvania (PPO)
- Devoted Health Choice Pennsylvania (PPO)
- Devoted Health Choice Plus Pennsylvania (PPO)
- Devoted Health Core Pennsylvania (HMO)
- Devoted Health Dual Plus Pennsylvania (HMO D-SNP)
- Devoted Health Giveback Pennsylvania (HMO)
Locations
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
- Pennsylvania Hospital: Has privileges to treat patients in the hospital.
- Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Qualifications and experience
- Neurology, 1995
- American Academy of Neurology, National
- American Academy of Neurology, National
- Bayer Healthcare, International
- Biogen-Idec, International
- BioMS, International
- Bristol Meyers Squib, International
- EMD Serono, International
- Genentech, International
- International Multiple Sclerosis Forum, International
- Multiple Sclerosis Cooperative Research Group (MS-CORE), National
- National Multiple Sclerosis Society, Delaware Valley Chapter, Local
- Novartis, International
- Penn Neuro Care-MS Section, Local
- Pfizer, International
- Teva Neuroscience, International
- Wyeth, International
- Recognized annually in Philadelphia Magazine's Top Docs issue from 2018 through 2025
Treatments and conditions
Research
Publications
Fox EJ, Markowitz C, Applebee A, Montalban X, Wolinsky JS, Belachew S, Fiore D, Pei J, Musch B, Giovannoni G Ocrelizumab reduces progression of upper extremity impairment in patients with primary progressive multiple sclerosis: Findings from the phase III randomized ORATORIO trial. , Mult Scler. : 2018
Cehelyk EK, Harvey DY, Grubb ML, Jalel R, El-Sibai MS, Markowitz CE, Berger JR, Hamilton RH, Chahin S Uncovering the association between fatigue and fatigability in multiple sclerosis using cognitive control. , Mult Scler Relat Disord. , 27: 2018,269-275
Fox E, Markowitz C, Applebee A, et al Effect of ocrelizumab on upper limb function in patients with primary progressive multiple sclerosis (PPMS) in the oratorio study (ENCORE) , J Neurol Neurosurg Psychiatry, 89(A14): 2018
Sahin N, Selouan R, Markowitz CE, Melhem ER, Bilello M Limbic pathway lesions in patients with multiple sclerosis. , Acta Radiol., 57(3): 2016,341-7
Salim Chahin, MD; Deborah Miller, PhD; Reiko Sakai; James Wilson; Clyde Markowitz, MD; Dina Jacobs, MD; Ari Green, MD; Peter A. Calabresi, MD; Elliot M. Frohman, MD; Steven Galetta, MD; Laura Balcer, MD, MSCE: Fatigue in Multiple Sclerosis: Relation to Quantitative Neurologic and Visual Outcomes. , Multiple Sclerosis and related disorders: 2015
Jose Torres, Amy Pruitt, Laura Balcer, Steven Galetta, Clyde Markowitz, Nabila Dahodwala Analysis of the treatment of neuromyelitis optica , Journal of the Neurological Sciences , 351(1): 2015
Salim Chahin, Deborah Miller, Reiko E. Sakai, James A. Wilson, Teresa Frohman, Clyde Markowitz, Dina Jacobs, Ari Green, Peter A. Calabresi, Elliot M. Frohman, Steven L. Galetta, Laura J. Balcer Relation of quantitative Visual and neurologic outcomes to fatigue in multiple sclerosis , Multiple Sclerosis and Related Disorders, 4(4): 2015
Edward Fox, Barbara Green, Clyde Markowitz, Ronald Murray, Andrew D Goodman, Stephen J Glenski, Pippa Loupe, Jo Nita Cogburn The effect of scheduled antibody testing on treatment patterns in interferon-treated patients with multiple sclerosis , BMC Neurology , 14(1): 2014
Patricia K Coyle, Bruce A Cohen, Thomas Leist, Clyde Markowitz, Merrikay Oleen-Burkey, Marc Schwartz, Mark J Tullman, Howard Zwibel Therapy optimization in multiple sclerosis: a prospective observational study of therapy compliance and outcomes , BMC Neurology , 14(1): 2014
Miller Aaron E, Cohen Bruce A, Krieger Stephen C, Markowitz Clyde E, Mattson David H, Tselentis Helen N Constructing an adaptive care model for the management of disease-related symptoms throughout the course of multiple sclerosis--performance improvement CME. , Multiple sclerosis (Houndmills, Basingstoke, England): 2013